• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RUNX1 作为乳腺癌的一个新的分子靶标。

RUNX1 as a Novel Molecular Target for Breast Cancer.

机构信息

Department of Pharmacology and Pharmaceutical Chemistry, Faculty of Pharmacy, Universiti Teknologi MARA, Selangor, Malaysia.

出版信息

Clin Breast Cancer. 2022 Aug;22(6):499-506. doi: 10.1016/j.clbc.2022.04.006. Epub 2022 Apr 26.

DOI:10.1016/j.clbc.2022.04.006
PMID:35599145
Abstract

RUNX1 has long known for its role in hematopoiesis until recently it is implicated in human breast cancer pathogenesis. This has drawn attention in research as elevated expression of RUNX1 has been observed in invasive breast cancer, and mutations of the RUNX1 gene and its binding partner CBFβ have been identified in luminal breast cancer patients, many of which have attributed to the development and progression of the disease. Increasing number of evidence also shows the involvement of RUNX1 in breast cancer migration and invasion that may lead to breast cancer metastasis. However, more studies need to be conducted to better understand its roles in these particular subtypes in breast cancer. This is important as evidence so far indicates that there are discrepancies with regards to the roles of RUNX1 in ER-positive and ER-negative breast cancer, both of which have posted a great challenge to recognize whether its deregulation is protecting or promoting breast cancer. This warrants further analysis to glean more information especially considering the perturbation of RUNX1 is mainly reported in ER-positive breast cancer. In this review, the roles of RUNX1 in breast cancer are discussed in a context dependent manner based on its involvement in the development and progression of the disease. The association of RUNX1 with other types of cancer is also included to emphasize a wider and possibly a different angle of involvement of RUNX1 in cancer.

摘要

RUNX1 长期以来一直因其在造血中的作用而为人所知,直到最近,它才被牵涉到人类乳腺癌的发病机制中。这引起了研究人员的关注,因为在浸润性乳腺癌中观察到 RUNX1 的表达升高,并且在腔乳腺癌患者中已经鉴定出 RUNX1 基因及其结合伴侣 CBFβ的突变,其中许多突变归因于疾病的发展和进展。越来越多的证据还表明 RUNX1 参与乳腺癌的迁移和侵袭,这可能导致乳腺癌转移。然而,还需要更多的研究来更好地理解它在乳腺癌这些特定亚型中的作用。这很重要,因为到目前为止的证据表明,RUNX1 在 ER 阳性和 ER 阴性乳腺癌中的作用存在差异,这两者都对识别其失调是保护还是促进乳腺癌提出了巨大挑战。这需要进一步分析以获取更多信息,特别是考虑到 RUNX1 的失调主要在 ER 阳性乳腺癌中报道。在这篇综述中,根据 RUNX1 参与疾病的发展和进展,以依赖于上下文的方式讨论了 RUNX1 在乳腺癌中的作用。还包括了 RUNX1 与其他类型癌症的关联,以强调 RUNX1 可能在癌症中涉及更广泛和可能不同的角度。

相似文献

1
RUNX1 as a Novel Molecular Target for Breast Cancer.RUNX1 作为乳腺癌的一个新的分子靶标。
Clin Breast Cancer. 2022 Aug;22(6):499-506. doi: 10.1016/j.clbc.2022.04.006. Epub 2022 Apr 26.
2
Relationship between RUNX1 and AXIN1 in ER-negative versus ER-positive Breast Cancer.雌激素受体阴性与雌激素受体阳性乳腺癌中RUNX1与AXIN1的关系
Cell Cycle. 2017 Feb 16;16(4):312-318. doi: 10.1080/15384101.2016.1237325. Epub 2017 Jan 5.
3
The RUNX Transcriptional Coregulator, CBFβ, Suppresses Migration of ER Breast Cancer Cells by Repressing ERα-Mediated Expression of the Migratory Factor TFF1.RUNX 转录共激活因子 CBFβ 通过抑制 ERα 介导的迁移因子 TFF1 的表达来抑制 ER 阳性乳腺癌细胞的迁移。
Mol Cancer Res. 2019 May;17(5):1015-1023. doi: 10.1158/1541-7786.MCR-18-1039. Epub 2019 Jan 17.
4
RUNX1-dependent mechanisms in biological control and dysregulation in cancer.RUNX1 依赖性机制在生物调控和癌症失调中的作用。
J Cell Physiol. 2019 Jun;234(6):8597-8609. doi: 10.1002/jcp.27841. Epub 2018 Dec 4.
5
Increased RUNX1 mutations in breast cancer disease progression.
Pathol Res Pract. 2024 Feb;254:155076. doi: 10.1016/j.prp.2023.155076. Epub 2024 Jan 4.
6
Runx1 is associated with breast cancer progression in MMTV-PyMT transgenic mice and its depletion in vitro inhibits migration and invasion.Runx1与MMTV-PyMT转基因小鼠的乳腺癌进展相关,其在体外的缺失会抑制迁移和侵袭。
J Cell Physiol. 2015 Oct;230(10):2522-32. doi: 10.1002/jcp.24989.
7
RUNX1 prevents oestrogen-mediated AXIN1 suppression and β-catenin activation in ER-positive breast cancer.RUNX1可防止雌激素介导的雌激素受体阳性乳腺癌中AXIN1抑制和β-连环蛋白激活。
Nat Commun. 2016 Feb 26;7:10751. doi: 10.1038/ncomms10751.
8
The enigmatic role of RUNX1 in female-related cancers - current knowledge & future perspectives.RUNX1 在女性相关癌症中的神秘作用——现有知识与未来展望。
FEBS J. 2017 Aug;284(15):2345-2362. doi: 10.1111/febs.14059. Epub 2017 Apr 10.
9
Suppression of Breast Cancer Stem Cells and Tumor Growth by the RUNX1 Transcription Factor.RUNX1 转录因子抑制乳腺癌干细胞和肿瘤生长。
Mol Cancer Res. 2018 Dec;16(12):1952-1964. doi: 10.1158/1541-7786.MCR-18-0135. Epub 2018 Aug 6.
10
RUNX1 and FOXP3 interplay regulates expression of breast cancer related genes.RUNX1与FOXP3相互作用调节乳腺癌相关基因的表达。
Oncotarget. 2016 Feb 9;7(6):6552-65. doi: 10.18632/oncotarget.6771.

引用本文的文献

1
DDR1 regulates RUNX1-CBFβ to control breast stem cell differentiation.DDR1调节RUNX1-CBFβ以控制乳腺干细胞分化。
Stem Cell Reports. 2025 Aug 12;20(8):102576. doi: 10.1016/j.stemcr.2025.102576. Epub 2025 Jul 3.
2
Coupling of Intracellular Calcium Homeostasis and Formation and Secretion of Matrix Vesicles: Their Role in the Mechanism of Biomineralization.细胞内钙稳态与基质小泡形成及分泌的耦合:它们在生物矿化机制中的作用。
Cells. 2025 May 17;14(10):733. doi: 10.3390/cells14100733.
3
UID-Dual Transcriptome Sequencing Analysis of the Molecular Interactions between and Mammary Epithelial Cells.
UID-与乳腺上皮细胞之间分子相互作用的双转录组测序分析
Animals (Basel). 2024 Sep 5;14(17):2587. doi: 10.3390/ani14172587.
4
RNA-Independent Regulatory Functions of lncRNA in Complex Disease.长链非编码RNA在复杂疾病中不依赖RNA的调控功能
Cancers (Basel). 2024 Jul 31;16(15):2728. doi: 10.3390/cancers16152728.
5
[Latest Findings on the Role of RUNX1 in Bone Development and Disorders].[RUNX1在骨骼发育和疾病中的作用的最新发现]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2024 Mar 20;55(2):256-262. doi: 10.12182/20240360103.
6
RUNX1 facilitates heart failure progression through regulating TGF-β-induced cardiac remodeling.RUNX1 通过调节 TGF-β 诱导的心脏重构促进心力衰竭的进展。
PeerJ. 2023 Oct 31;11:e16202. doi: 10.7717/peerj.16202. eCollection 2023.
7
Recent Advances in Transcription Factors Biomarkers and Targeted Therapies Focusing on Epithelial-Mesenchymal Transition.聚焦上皮-间质转化的转录因子生物标志物与靶向治疗的最新进展
Cancers (Basel). 2023 Jun 25;15(13):3338. doi: 10.3390/cancers15133338.
8
RUNX1 promotes liver fibrosis progression through regulating TGF-β signalling.RUNX1 通过调节 TGF-β 信号促进肝纤维化进展。
Int J Exp Pathol. 2023 Aug;104(4):188-198. doi: 10.1111/iep.12474. Epub 2023 Apr 17.